Crossref
Real-World Efficacy and Safety of Endostar-Platinum versus Bevacizumab-Platinum Intracavitary Perfusion for Serous Cavity Effusions
International Journal of Frontiers in Medicine · 2026 · 8 (1)
DOI: 10.25236/ijfm.2026.080103 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Frontiers in Medicine, 2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Real-World Efficacy and Safety of Endostar-Platinum versus Bevacizumab-Platinum Intracavitary Perfusion for Serous Cavity Effusions. International Journal of Frontiers in Medicine, 8(1). https://doi.org/10.25236/ijfm.2026.080103
Vancouver
Real-World Efficacy and Safety of Endostar-Platinum versus Bevacizumab-Platinum Intracavitary Perfusion for Serous Cavity Effusions. International Journal of Frontiers in Medicine. 2026;8(1). doi:10.25236/ijfm.2026.080103
BibTeX
@article{euvimed2026,
title = {Real-World Efficacy and Safety of Endostar-Platinum versus Bevacizumab-Platinum Intracavitary Perfusion for Serous Cavity Effusions},
journal = {International Journal of Frontiers in Medicine},
year = {2026},
volume = {8},
number = {1},
doi = {10.25236/ijfm.2026.080103}
}
EUVIMED